ARIAD PHARMACEUTICALS INC 4
4 · ARIAD PHARMACEUTICALS INC · Filed Jan 10, 2017
Insider Transaction Report
Form 4
Bollag Daniel M
Sr. VP, Reg. Affairs & Quality
Transactions
- Exercise/Conversion
Common Stock
2017-01-09$7.82/sh+32,000$250,240→ 161,404 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2017-01-09−32,000→ 0 totalExercise: $7.82From: 2012-04-01Exp: 2021-04-01→ Common Stock (32,000 underlying) - Sale
Common Stock
2017-01-09$23.78/sh−32,000$760,960→ 129,404 total
Footnotes (2)
- [F1]Shares were acquired from exercise of an outstanding stock option pursuant to a Rule 10b5-1 trading plan adopted on June 15, 2016
- [F2]Shares were sold pursuant to a Rule 10b5-1 trading plan dated June 15, 2016